Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Amiodarone does not affect digoxin kinetics in the rabbit.

D C Buss, P A Routledge

    The Journal of Pharmacy and Pharmacology
    |September 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A change in the trend in dosulepin usage following the introduction of a prescribing indicator but not after two national safety warnings.

    Journal of clinical pharmacy and therapeutics·2016
    Same author

    A comparative study of methyldopa and labetalol in the treatment of hypertension.

    British journal of clinical pharmacology·2015
    Same author

    Mean steady-state plasma concentrations of labetalol in patients undergoing antihypertensive therapy.

    British journal of clinical pharmacology·2015
    Same author

    A multicentre open trial of labetalol in New Zealand.

    British journal of clinical pharmacology·2015
    Same author

    Impact of anti-cancer drugs and other determinants on serum protein binding of morphine 6-glucuronide.

    Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences·2012
    Same author

    Evidence of active transport involvement in morphine transport via MDCKII and MDCK-PGP cell lines.

    Research in pharmaceutical sciences·2011
    Same journal

    Farnesoid X receptor blockade attenuates morphological damage, intestinal secretion, and prevents mucus loss induced by SARS-CoV-2 spike protein in the mouse intestine.

    The Journal of pharmacy and pharmacology·2026
    Same journal

    Therapeutic strategies of traditional Chinese medicine for chronic heart failure: from active ingredients to herbal formulations.

    The Journal of pharmacy and pharmacology·2026
    Same journal

    Norisoboldine suppresses epithelial-mesenchymal transition in colorectal cancer by simultaneously inhibiting the CXCR4/CXCR7 chemokine receptors and the JAK/STAT3 signaling pathway.

    The Journal of pharmacy and pharmacology·2026
    Same journal

    Development, characterization, and therapeutic evaluation of uniform dezocine-loaded PLGA microspheres for sustained analgesia and cognitive protection.

    The Journal of pharmacy and pharmacology·2026
    Same journal

    Phytochemical constituents, biological activities, toxicological profiles, and current applications of Muntingia calabura L.: an updated review.

    The Journal of pharmacy and pharmacology·2026
    Same journal

    Uterine relaxant effects of Ageratum conyzoides essential oil: influence of hormonal status and calcium modulation.

    The Journal of pharmacy and pharmacology·2026
    See all related articles

    Amiodarone did not significantly alter digoxin pharmacokinetics in rabbits. Further animal models are needed to study this potential drug interaction.

    Area of Science:

    • Pharmacology
    • Drug Interactions
    • Toxicology

    Background:

    • Amiodarone is known to potentially interact with digoxin in humans.
    • Understanding this interaction is crucial for patient safety.

    Purpose of the Study:

    • To investigate the pharmacokinetic effects of amiodarone pretreatment on digoxin in a rabbit model.
    • To determine if amiodarone influences digoxin's absorption, distribution, metabolism, or excretion.

    Main Methods:

    • Six rabbits received amiodarone pretreatment (35 mg/kg/day).
    • A single dose of digoxin (50 µg/kg) was administered.
    • Pharmacokinetic parameters including total body clearance, serum half-life, and volume of distribution were measured before and after amiodarone treatment.

    Related Experiment Videos

    Main Results:

    • No statistically significant changes were observed in digoxin's total body clearance, serum half-life, or volume of distribution after amiodarone pretreatment.
    • The pharmacokinetic profile of digoxin remained largely unchanged in rabbits treated with amiodarone.

    Conclusions:

    • Amiodarone-induced changes in digoxin pharmacokinetics were not evident in the rabbit model.
    • Additional animal models may be required to adequately study the amiodarone-digoxin interaction.